Lopez-Talavera JC - Search Results

1

Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis.

Luca A, García-Pagán JC, Feu F, Lopez-Talavera JC, Fernández M, Bru C, Bosch J, Rodés J. Luca A, et al. Hepatology. 1995 Jan;21(1):83-8. Hepatology. 1995. PMID: 7806173 Clinical Trial.

2

Interferon-alpha in acute posttransfusion hepatitis C: a randomized, controlled trial.

Viladomiu L, Genescà J, Esteban JI, Allende H, González A, López-Talavera JC, Esteban R, Guardia J. Viladomiu L, et al. Hepatology. 1992 May;15(5):767-9. doi: 10.1002/hep.1840150504. Hepatology. 1992. PMID: 1568716 Clinical Trial.

3

Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats.

Lopez-Talavera JC, Cadelina G, Olchowski J, Merrill W, Groszmann RJ. Lopez-Talavera JC, et al. Hepatology. 1996 Jun;23(6):1616-21. doi: 10.1002/hep.510230644. Hepatology. 1996. PMID: 8675185

4

Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.

López-Talavera JC, Levitzki A, Martínez M, Gazit A, Esteban R, Guardia J. López-Talavera JC, et al. J Clin Invest. 1997 Aug 1;100(3):664-70. doi: 10.1172/JCI119578. J Clin Invest. 1997. PMID: 9239414 Free PMC article.

5

Outcome and hepatic hemodynamics in liver transplant patients with portal vein arterialization.

Charco R, Margarit C, López-Talavera JC, Hidalgo E, Castells L, Allende H, Segarra A, Moreíras M, Bilbao I. Charco R, et al. Am J Transplant. 2001 Jul;1(2):146-51. Am J Transplant. 2001. PMID: 12099362 Free article.

6

Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.

Genesca J, Gonzalez A, Segura R, Catalan R, Marti R, Varela E, Cadelina G, Martinez M, Lopez-Talavera JC, Esteban R, Groszmann RJ, Guardia J. Genesca J, et al. Am J Gastroenterol. 1999 Jan;94(1):169-77. doi: 10.1111/j.1572-0241.1999.00790.x. Am J Gastroenterol. 1999. PMID: 9934750

7

Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats.

Sieber CC, Lopez-Talavera JC, Groszmann RJ. Sieber CC, et al. Gastroenterology. 1993 Jun;104(6):1750-4. doi: 10.1016/0016-5085(93)90655-v. Gastroenterology. 1993. PMID: 8388839 Free article.

8

Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1.

Nettles RE, Gao M, Bifano M, Chung E, Persson A, Marbury TC, Goldwater R, DeMicco MP, Rodriguez-Torres M, Vutikullird A, Fuentes E, Lawitz E, Lopez-Talavera JC, Grasela DM. Nettles RE, et al. Hepatology. 2011 Dec;54(6):1956-65. doi: 10.1002/hep.24609. Hepatology. 2011. PMID: 21837752 Clinical Trial.

9

Detection of hepatitis delta virus RNA in human liver tissue by non-radioactive in situ hybridization.

Lopez-Talavera JC, Buti M, Casacuberta J, Allende H, Jardi R, Esteban R, Guardia J. Lopez-Talavera JC, et al. J Hepatol. 1993 Feb;17(2):199-203. doi: 10.1016/s0168-8278(05)80038-8. J Hepatol. 1993. PMID: 8445232

10

Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir.

Leung N, Peng CY, Hann HW, Sollano J, Lao-Tan J, Hsu CW, Lesmana L, Yuen MF, Jeffers L, Sherman M, Min A, Mencarini K, Diva U, Cross A, Wilber R, Lopez-Talavera J. Leung N, et al. Hepatology. 2009 Jan;49(1):72-9. doi: 10.1002/hep.22658. Hepatology. 2009. PMID: 19065670 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters